Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,949 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Recruiting

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

NCT06529822

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations: AdventHealth Orlando, Florida, United States

Washington University School of Medicine St Louis, Missouri, United States

Ohio State University Columbus, Ohio, United States

View Trial Details

Recruiting

Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer

NCT00050752

Conditions: Cutaneous Leiomyoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Evaluation for NCI Surgery Branch Clinical Research Protocols

NCT00001823

Conditions: Bladder Cancer, Colonic Diseases, Colorectal Cancer, +36 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions: Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations: Precision NextGen Oncology Beverly Hills, California, United States

OPN Healthcare, Inc Glendale, California, United States

University of Southern California Los Angeles, California, United States

MDR Core Network Boynton Beach, Florida, United States

View Trial Details

Recruiting

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

NCT05092373

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Breast Carcinoma, +110 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

NCT06966024

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

University of Michigan Ann Arbor, Michigan, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Vanderbilt- Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Recruiting

Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer

NCT07128680

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Advanced Sarcomatoid Renal Cell Carcinoma, +20 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope Medical Center Irvine, California, United States

View Trial Details

Recruiting

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

NCT07049926

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: UCSF Medical Center at Mission Bay ( Site 5008) San Francisco, California, United States

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 5026) Mineola, New York, United States

Laura and Isaac Perlmutter Cancer Center ( Site 5016) New York, United States

Memorial Sloan Kettering Cancer Center ( Site 5002) New York, United States

View all 30 locations

View Trial Details

Recruiting

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

NCT02830724

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Cancer, +41 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

NCT04981509

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

Emory Saint Joseph's Hospital Atlanta, Georgia, United States

View all 13 locations

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions